A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.
about
Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusionInhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat regionIdentification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent mannerConformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions.Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.Theoretical and functional analysis of the SIV fusion peptideEvidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.Cell fusion induced by the murine leukemia virus envelope glycoproteinTruncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivityIdentification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like regioMutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15EThe role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection.A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
P2860
Q24811678-48E14606-C10C-4BD0-BF78-B65F7B2CA71AQ28646771-E23727C3-0724-45EA-9006-64DAD7466E13Q28646837-97B4A332-229F-41A5-90D7-6FA3CB3FBEE2Q33724327-C707ACA8-294C-4684-9826-AA008707EBDEQ33935988-4A90A279-A19D-41D7-81EC-59CCE1B95105Q34104639-BEC3163E-4253-4F8B-8D72-BD45EC516384Q34179319-4F408E89-0E7A-4114-878D-A9F3A5B50AAAQ35835261-DC62AB43-8851-4AFC-A766-A6AABD91F4B7Q35853659-68D4A66A-114D-45DC-99F7-5E1BC676680CQ35930676-11DCC59F-2BF3-47D4-8A11-8A96CFE255BEQ36632356-B92EBEF1-6219-4CCC-BDF2-3E6A2E0294B7Q36638864-EBB9011E-D0C8-4100-8F37-CC4D5634A5E0Q36645772-1C604611-FDF5-44D8-9654-5D46DC380214Q36685270-2D3AC41A-68F2-4A0C-9D9D-FB0169DBC5DAQ36687883-D6825E64-F766-4EE9-A769-0BF5EF8C03F8Q36699051-9E0BA36C-C91F-43BD-81C9-C8D0C847B130Q36699125-FBC26E27-7DFF-41A8-BAA8-79091464422DQ36831564-3AA0F68B-48E4-4BFD-8330-F4A2FFB5E2EDQ36848421-DDA6D613-4372-430B-9FE8-4212839ED505Q37191116-1C10719C-7161-4098-816D-F848D9CF7242Q37594056-D0D914BD-7912-4363-B277-E43AABA72ECDQ39642472-12B32C2D-0192-4366-B0E0-76C50F808DFDQ40433970-12EE1614-7B56-4174-85A8-B6F3951D21FFQ41459533-1E7061BD-1782-407D-8182-0570AC86137B
P2860
A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
A syncytia assay for human imm ...... e in studying HIV-I mutations.
@en
A syncytia assay for human immunodeficiency virus type I
@nl
type
label
A syncytia assay for human imm ...... e in studying HIV-I mutations.
@en
A syncytia assay for human immunodeficiency virus type I
@nl
prefLabel
A syncytia assay for human imm ...... e in studying HIV-I mutations.
@en
A syncytia assay for human immunodeficiency virus type I
@nl
P2093
P1433
P1476
A syncytia assay for human imm ...... e in studying HIV-I mutations.
@en
P2093
P304
P356
10.1016/0042-6822(89)90448-0
P407
P577
1989-06-01T00:00:00Z